24
Participants
Start Date
January 31, 2001
Primary Completion Date
January 31, 2006
Study Completion Date
January 31, 2006
Rituximab
Subjects received four weekly infusions of rituximab at a dose of 375 mg/m\^2
University of Rochester, Rochester
University of Pennsylvania, Philadelphia
University of Colorado, Denver
Autoimmunity Centers of Excellence
OTHER
National Institute of Allergy and Infectious Diseases (NIAID)
NIH